Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 193

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications

Hou, Jiajie, Zhang, Haiyan, Sun, Beicheng, Karin, Michael · 2020 · Journal of Hepatology

Abstract

Basic and clinical studies have demonstrated the efficacy of immunotherapy, a technical and conceptual breakthrough that has revolutionized cancer treatment. Hepatocellular carcinoma (HCC), a deadly malignancy with etiologic diversity and a chronic course, is strongly influenced by the immune system, and was recently found to partially benefit from immune checkpoint inhibitor therapy. Notably, HCC onco-immunology depends on diverse genetic and environmental factors that together shape cancer-promoting inflammation as well as immune dysfunction, critical processes that control HCC malignant progression and response to therapy. Here we summarize current understanding of liver and HCC oncoimmunology obtained through basic studies with mouse models and clinical practice in humans. In particular, we discuss preclinical and clinical findings that implicate immunomodulation as a major factor in HCC development and explain the basis for HCC-targeting immunotherapy. LAY SUMMARY: Chronic inflammation and immune dysfunction are important contributors to the onset and progression of the most common form of liver cancer-hepatocellular carcinoma (HCC). Although progress in HCC treatment and prevention has been slow, recent studies suggest that immune-based cancer therapies may revolutionize its treatment. We explain the basic concepts and clinical science underlying a portion of the patient population. However, many challenges for future research remain, including improved methodology for identifying patients likely to benefit from HCC immunotherapy and discovery of supplements that can further augment therapeutic response rates to HCC immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2019.08.014

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 193

Metadata

Authors
Hou, J., Zhang, H., Sun, B., & Karin, M.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2020-01
Volume
72
Issue
1
Pages
167-182
ISSN
0168-8278 (ISSN-L)
OpenAlex
W2969583426
Cited by
193
References
41
FWCI
16.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.